OptimizeRx CorporationFind Ratings Reports
OPTIMIZERX CORP's gross profit margin for the first quarter of its fiscal year 2021 is essentially unchanged when compared to the same period a year ago. The company grew its sales and net income significantly quarter versus same quarter a year prior, and was able to outpace the average competitor in the subsector when comparing revenue growth, but not when comparing net income growth. OPTIMIZERX CORP is extremely liquid. Currently, the Quick Ratio is 17.87 which clearly shows the ability to cover any short-term cash needs. OPRX managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.
At the same time, stockholders' equity ("net worth") has greatly increased by 179.27% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY21||Q1 FY20|
|Net Sales ($mil)||11.23||7.59|
|Net Income ($mil)||-0.64||-2.2|
|Balance Sheet||Q1 FY21||Q1 FY20|
|Cash & Equiv. ($mil)||82.28||15.21|
|Total Assets ($mil)||127.57||56.24|
|Total Debt ($mil)||0.42||0.54|
|Profitability||Q1 FY21||Q1 FY20|
|Gross Profit Margin||54.54||57.26|
|Return on Assets||-0.5||-9.52|
|Return on Equity||-0.53||-12.27|
|Debt||Q1 FY21||Q1 FY20|
|Share Data||Q1 FY21||Q1 FY20|
|Shares outstanding (mil)||17.26||14.65|
|Div / share||0.0||0.0|
|Book value / share||7.06||2.98|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||151546.0||288944.0|
HOLD. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. To use another comparison, its price-to-book ratio of 7.82 indicates a significant premium versus the S&P 500 average of 4.59 and a significant discount versus the subsector average of 10.22. The price-to-sales ratio is well above the S&P 500 average, but well below the subsector average. After reviewing these and other key valuation criteria, OPTIMIZERX CORP proves to trade at a discount to investment alternatives.
|OPRX NM||Peers 100.38||OPRX NM||Peers 98.55|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
OPRX's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
OPRX's P/CF is negative making the measure meaningless.
|OPRX 71.68||Peers 68.62||OPRX NA||Peers 2.16|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
OPRX is trading at a significant premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|OPRX 7.82||Peers 10.22||OPRX 86.49||Peers -26.63|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
OPRX is trading at a discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
OPRX is expected to have an earnings growth rate that significantly exceeds its peers.
|OPRX 20.29||Peers 26.86||OPRX 74.08||Peers 183.60|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
OPRX is trading at a discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
OPRX significantly trails its peers on the basis of sales growth.